News for Healthier Living

Roswell Park Team Discovers New Treatment Target for Neuroendocrine Prostate Cancer

A team of researchers at Roswell Park , led by Dhyan Chandra, PhD, has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat form of prostate cancer. Their findings, newly published in the journal Oncogene, suggest that a set of processes known as the mitochondrial unfolded protein response, could be an Achilles' heel for this often-deadly cancer type, and may point the way to a new treatment approach.

December 18, 2024


January 1 2025

December 31 2024

December 30 2024

December 29 2024

December 28 2024

December 27 2024

December 26 2024

December 24 2024

December 23 2024

December 21 2024

December 20 2024

December 19 2024